Literature DB >> 17389757

Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects.

F Runa Ali1, A Barry Kay, Mark Larché.   

Abstract

BACKGROUND: Subjects with allergic asthma develop isolated late asthmatic reactions after inhalation of allergen-derived T cell peptides. Animal experiments have shown that airway hyperresponsiveness (AHR) is CD4+ cell-dependent. It is hypothesised that peptide inhalation produces increases in non-specific AHR and a T cell-dominant bronchial mucosal inflammatory response.
METHODS: Bronchoscopy, with bronchial biopsies and bronchoalveolar lavage (BAL), was performed in 24 subjects with cat allergy 6 h after aerosol inhalation of short overlapping peptides derived from Fel d 1, the major cat allergen. Biopsy specimens and BAL fluid were studied using immunohistochemistry and ELISA.
RESULTS: Twelve of the 24 subjects developed an isolated late asthmatic reaction without a preceding early (mast cell/histamine-dependent) reaction characteristic of whole allergen inhalation. These responders had significant between-group differences (responders vs non-responders) in the changes (peptide vs diluent) in AHR (p = 0.007) and bronchial mucosal CD3+ (p = 0.005), CD4+ (p = 0.006) and thymus- and activation-regulated chemokine (TARC)+ (p = 0.003) but not CD8+ or CD25+ cells or eosinophils, basophils, mast cells and macrophages. The between-group difference for neutrophils was p = 0.05 but with a non-significant within-group value (peptide vs diluent, responders, p = 0.11). In BAL fluid there was a significant between-group difference in TARC (p = 0.02) but not in histamine, tryptase, basogranulin, C3a or C5a, leukotrienes C(4)/D(4)/E(4), prostaglandins D(2) or F(2alpha).
CONCLUSIONS: Direct activation of allergen-specific airway T cells by peptide inhalation in patients with atopic asthma leads to increased AHR with local increases in CD3+ and CD4+ cells and TARC but no significant changes in eosinophils or basophil/mast cell products. These findings support previous animal experiments which showed a CD4+ dependence for AHR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389757      PMCID: PMC2117301          DOI: 10.1136/thx.2006.072041

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid.

Authors:  B M Haselden; M Larché; Q Meng; K Shirley; R Dworski; A P Kaplan; C Bates; D S Robinson; S Ying; A B Kay
Journal:  J Allergy Clin Immunol       Date:  2001-09       Impact factor: 10.793

2.  Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions.

Authors:  P Diaz; M C Gonzalez; F R Galleguillos; P Ancic; O Cromwell; D Shepherd; S R Durham; G J Gleich; A B Kay
Journal:  Am Rev Respir Dis       Date:  1989-06

3.  Allergen-induced increase in non-allergic bronchial reactivity.

Authors:  D W Cockcroft; R E Ruffin; J Dolovich; F E Hargreave
Journal:  Clin Allergy       Date:  1977-11

4.  Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects.

Authors:  W L Oldfield; A B Kay; M Larché
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.

Authors:  G O Solley; G J Gleich; R E Jordon; A L Schroeter
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

6.  Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber.

Authors:  A Cartier; N C Thomson; P A Frith; R Roberts; F E Hargreave
Journal:  J Allergy Clin Immunol       Date:  1982-09       Impact factor: 10.793

7.  Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine.

Authors:  D W Cockcroft; R E Ruffin; P A Frith; A Cartier; E F Juniper; J Dolovich; F E Hargreave
Journal:  Am Rev Respir Dis       Date:  1979-11

8.  Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in Sudden Infant Death Syndrome (SIDS). An investigation of anaphylactic mechanisms.

Authors:  M G Buckley; S Variend; A F Walls
Journal:  Clin Exp Allergy       Date:  2001-11       Impact factor: 5.018

9.  A role for the C3a anaphylatoxin receptor in the effector phase of asthma.

Authors:  A A Humbles; B Lu; C A Nilsson; C Lilly; E Israel; Y Fujiwara; N P Gerard; C Gerard
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

10.  Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics.

Authors:  A M Bentley; Q Meng; D S Robinson; Q Hamid; A B Kay; S R Durham
Journal:  Am J Respir Cell Mol Biol       Date:  1993-01       Impact factor: 6.914

View more
  4 in total

Review 1.  Which biomarkers are effective for identifying Th2-driven inflammation in asthma?

Authors:  Zuzana Diamant; Ellen Tufvesson; Leif Bjermer
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

2.  In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity.

Authors:  Ola B Nilsson; Justus Adedoyin; Claudio Rhyner; Theresa Neimert-Andersson; Jeanette Grundström; Kurt D Berndt; Reto Crameri; Hans Grönlund
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

Review 3.  Human CD8+ T Cells in Asthma: Possible Pathways and Roles for NK-Like Subtypes.

Authors:  Olga Lourenço; Ana Mafalda Fonseca; Luis Taborda-Barata
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

4.  CD4⁺ and CD8⁺ T cells play a central role in a HDM driven model of allergic asthma.

Authors:  Kristof Raemdonck; Katie Baker; Nicole Dale; Eric Dubuis; Fisnik Shala; Maria G Belvisi; Mark A Birrell
Journal:  Respir Res       Date:  2016-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.